| Literature DB >> 29769451 |
Fuminori Tanihara1, Maki Hirata1, Nguyen Thi Nhien1, Takayuki Hirano1, Toshiki Kunihara1, Takeshige Otoi1.
Abstract
The value of laboratory and genetically-modified pigs is becoming increasingly clear; however, their in vitro development remains inefficient. Trans-ferulic acid (trans-FA) is an aromatic compound that is abundant in plant cell walls, and which exhibits antioxidant effects in vitro. Trans-FA is known to improve sperm viability and motility; however, its effects on porcine oocytes are unknown. Our aim was to investigate the effects of trans-FA supplementation during in vitro maturation on the meiotic and developmental competence of porcine oocytes. Oocytes were matured either without (control) or with trans-FA (10, 100 and 1,000 µM), fertilized, and cultured in vitro for 7 days. The maturation rate of oocytes cultured with 10 µM trans-FA (81.6%) was significantly higher than that of controls (65.0%; P<0.05). The fertilization rate of oocytes matured with 10 µM trans-FA (57.4%) was also significantly higher than that of controls (32.7%) and oocytes cultured with other concentrations (33.1% and 22.7% for 100 and 1,000 µM, respectively; P<0.05). Moreover, the blastocyst formation rate of oocytes matured with 10 µM trans-FA (6.9%) was significantly higher than that of controls (2.3%; P<0.05). Our results suggest that in vitro maturation with 10 µM trans-FA is beneficial for the in vitro production of porcine embryos and has the potential to improve production system.Entities:
Keywords: antioxidant; developmental competence; embryo; oxidative stress; trans-ferulic acid
Mesh:
Substances:
Year: 2018 PMID: 29769451 PMCID: PMC6021867 DOI: 10.1292/jvms.18-0131
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Effects of trans-ferulic acid (trans-FA) supplementation during in vitro maturation culture on the maturation, fertilization and development of porcine oocytes*
| Concentration of trans-FA ( | No. of examined oocytes | No. (%)** of matured oocytes | No. of examined oocytes | No. of oocytes | No. of examined embryos | No. of embryos | No. of cells in blastocyst | ||
|---|---|---|---|---|---|---|---|---|---|
| Fertilized (%) | Monospermy (%)*** | Cleaved (%) | Developed to blastocysts (%) | ||||||
| 0 | 72 | 49 (65.0 ± 3.6)a) | 64 | 22 (32.7 ± 4.1)a) | 18 (82.7 ± 8.4) | 181 | 151 (83.1 ± 3.3)a,b) | 4 (2.3 ± 0.6)a) | 45.9 ± 10.6 |
| 10 | 72 | 60 (81.6 ± 5.6)b) | 63 | 35 (57.4 ± 11.5)b) | 26 (80.5 ± 10.7) | 189 | 164 (86.3 ± 3.3)a) | 14 (6.9 ± 2.1)b) | 36.3 ± 4.1 |
| 100 | 70 | 46 (66.2 ± 8.1)a,b) | 66 | 19 (33.1 ± 7.9)a) | 13 (66.3 ± 11.6) | 193 | 141 (72.4 ± 5.2)b) | 9 (4.4 ± 1.5)a,b) | 36.9 ± 4.1 |
| 1,000 | 69 | 48 (67.3 ± 5.9)a,b) | 65 | 15 (22.7 ± 10.5)a) | 13 (91.4 ± 5.1) | 158 | 119 (75.2 ± 3.3)b) | 5 (3.1 ± 0.9)a,b) | 35.1 ± 3.3 |
*Five replicated trials were carried out. **Percentages are expressed as mean ± SEM. ***The monospermic fertilization rate was defined as a ratio of the number of monospermic oocytes and the total number of fertilized oocytes. a, b) Values with different superscripts in the same column differ significantly (P<0.05).